Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cdk4 inhibitor'

Search results for: 'cdk4 inhibitor'

Items 41-50 of 120

Page
per page
  1. U-104
    A4358 U-104
    Target: Carbonic Anhydrases
    Summary: CAIX inhibitor
      insoluble in H2O; ≥11.5 mg/mL
  2. U0126-EtOH
    A1337 U0126-EtOH
     10 Citation
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.33 mg/mL
  3. NVP-BEP800
    A4064 NVP-BEP800
    Target: HSP90
    Summary: Oral Hsp90β inhibitor, novel, fully synthetic
  4. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL
  5. Tivozanib (AV-951)
    A2251 Tivozanib (AV-951)
    Target: VEGFR
    Summary: VEGFR inhibitor,potent and selective
      ≥22.75 mg/mL
  6. Mitoxantrone HCl
    B2114 Mitoxantrone HCl
    Target: Pim|Topoisomerases|USP|HIV Integrases
    Summary: Topoisomerase II inhibitor, anti-neoplastic drug
      insoluble in EtOH; ≥51.53 mg/mL
  7. YM155
    A4221 YM155
     2 Citation
    Target: Survivin
    Summary: Survivin suppressant,apoptosis inhibitor
      ≥22.15 mg/mL
  8. XL147
    A5112 XL147
    Target: PI3K
    Summary: PI3K inhibitor,selective and reversible
      ≥22.45 mg/mL
  9. Nu 6027
    A1986 Nu 6027
    Target: Cyclin-Dependent Kinases|ATM/ATR
    Summary: ATR/CDK inhibitor, potent and selective
      insoluble in H2O; ≥12.55 mg/mL
  10. GSK1059615
    B2176 GSK1059615
    Target: PI3K|mTOR
    Summary: PI3K and mTOR inhibitor,potent and reversible
      insoluble in EtOH; insoluble in H2O; ≥8.33 mg/mL

Items 41-50 of 120

Page
per page
Shop By
Now Shopping by
  1. Related Disease Breast Cancer Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 117item
Specificity
  1. Selective 115item
Reversibility
  1. Reversible 9item
  2. Irreversible 3item
Target
  1. Cyclin-Dependent Kinases 6item
  2. Proteasome 2item
  3. Cathepsins 1 item
  4. Histone Deacetylases (HDACs) 10item
  5. Inhibitor of apoptosis proteins (IAP) 1 item
  6. Akt 3item
  7. Bcl-2 2item
  8. PI3K 8item
  9. CXCR 2item
  10. Aurora Kinases 4item
  11. Bcl-xl 2item
  12. CSF-1R 1 item
  13. EZH2 2item
  14. mTOR 5item
  15. Bromodomains 1 item
  16. DT-diaphorases 1 item
  17. FLT3 2item
  18. P-glycoprotein (P-gp) 1 item
  19. PLK 1 item
  20. Chk 1 item
  21. VEGFR 9item
  22. PDGFR 4item
  23. c-Kit 3item
  24. Mcl-1 2item
  25. Thymidylate Synthase 1 item
  26. p38 1 item
  27. 3-phosphoglycerate dehydrogenase 1 item
  28. Bcr-Abl 1 item
  29. MEK 5item
  30. PORCN 1 item
  31. FGFR 2item
  32. Pim 2item
  33. Smoothened 1 item
  34. MET 1 item
  35. Src 1 item
  36. Trk Receptors 1 item
  37. STAT 2item
  38. Microtubules/Tubulins 1 item
  39. EGFR 8item
  40. FAK 1 item
  41. BMP and Other Activin Receptors 1 item
  42. JAK 2item
  43. Syk 1 item
  44. HSP90 5item
  45. Topoisomerases 2item
  46. Cytochrome P450 (CYP450) 3item
  47. Ksp 1 item
  48. ErbB 1 item
  49. Survivin 1 item
  50. c-MET 1 item
  51. PKC 2item
  52. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  53. HER2 2item
  54. USP 1 item
  55. PARP 1 item
  56. ALK 1 item
  57. ROS1 1 item
  58. D1 and D5 Receptors 1 item
  59. D2 Receptors 1 item
  60. D3 Receptors 1 item
  61. MELK 1 item
  62. CSF1R 1 item
  63. Autophagy 1 item
  64. ATM/ATR 2item
  65. COX 1 item
  66. Heparanases 1 item
  67. CK2 1 item
  68. HIPK2 1 item
  69. HIPK3 1 item
  70. HIV Integrases 1 item
  71. PRAK 1 item
  72. MAPKAP-K2 1 item
  73. Guanine nucleotide exchange factors (GEFs) 1 item
  74. 20S proteasomal chymotrypsin 1 item
  75. Geranylgeranyltransferase I 1 item
  76. Farnesyltransferase 1 item
  77. Carbonic Anhydrases 1 item
  78. Histone Demethylases 1 item
  79. Insulin Receptors 1 item
  80. IRG-1R 1 item
  81. eEF-2 1 item
  82. D4 Receptors 1 item
  83. DPP-4 1 item
  84. Aromatases 2item
Reported Experiments
  1. Animal Experiments 113item
  2. Cell Experiments 71item